Trials / Unknown
UnknownNCT05427175
Evaluation of the Effect of Narrowband UVB Versus Methotrexate on Serum Chitotriosidase Level in Psoriasis
Evaluation of the Effect of Narrowband Ultraviolet B Versus Methotrexate on Serum Chitotriosidase Level in Psoriasis.
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Aswan University Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
The aim of the study is to evaluate the effect of NB-UVB versus MTX on serum Chitotriosidase level in psoriatic patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Narrowband ultraviolet B | Patients will receive 8 sessions of NB-UVB per month for 3 successive months |
| DRUG | Methotrexate | Patients will receive 25 mg/1ml of methotrexate vial per week for 3 successive months |
Timeline
- Start date
- 2022-01-10
- Primary completion
- 2023-07-01
- Completion
- 2023-09-15
- First posted
- 2022-06-22
- Last updated
- 2022-06-22
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05427175. Inclusion in this directory is not an endorsement.